Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
2.2 Fan Pass Share Issuance. Prior to the Spin-Off Date, Parent will take, or cause to be taken, all actions necessary to issue to Parent such number of shares of Common Stock, including, if applicable, by reclassifying the outstanding shares of Common Stock (the “Share Issuance”), for the purpose of increasing the outstanding shares of Common Stock such that, immediately prior to the Spin-Off Date, Fan Pass will have not less than an aggregate number of outstanding shares of Common Stock that is equal to one share of Common Stock for each share of Parent Common Stock issued and outstanding on the Record Date as well as sufficient shares of Common Stock for all conversions envisioned under the Surrender and Exchange Agreements concurrently executed which covers all convertible debt of Parent and all issued and outstanding shares of Series A Preferred Stock (collectively, the “Conversions”).
FAN PASS will assume the debt imo. Not sure how hard it is to not see that in the filings. It’s right there in black and white.
FDBL —-> Sharps Technology, inc.
Seems to me FDBL has been cleaned for Sharps Technology take over
..... which covers all convertible debt of Parent and all issued and outstanding shares of Series A Preferred Stock (collectively, the “Conversions”).
Fan Pass will have not less than an aggregate number of outstanding shares of Common Stock that is equal to one share of Common Stock for each share of Parent Common Stock issued and outstanding on the Record Date as well as sufficient shares of Common Stock for all conversions envisioned under the Surrender and Exchange Agreements concurrently executed which covers all convertible debt of Parent and all issued and outstanding shares of Series A Preferred Stock (collectively, the “Conversions”).
Someone will take out the 2’s soon
Bid just went to 400M. Wow
Revenues are derived from the patent licensing of the syringe to date imo. Going public opens a lot of doors to potential marketing and selling the product themselves. Possible production too imo.
Revenues are undisclosed so anyone saying $2B probably smokes too much weed.
I’m sure licensing the patent has done well enough for them to seek distribution of the technology themselves though. I’d be doing the same thing. imo.
After the merger I see $10-$20 a share here based on what I read about this stick-proof syringe.
Very Clever - Fan Pass will have not less than an aggregate number of outstanding shares of Common Stock that is equal to one share of Common Stock for each share of Parent Common Stock issued and outstanding on the Record Date as well as sufficient shares of Common Stock for all conversions envisioned under the Surrender and Exchange Agreements concurrently executed which covers all convertible debt of Parent and all issued and outstanding shares of Series A Preferred Stock (collectively, the “Conversions”).
By mismarking the trading ticket – checking the long box when it is actually a short sale the short never shows up, unless they get caught, which doesn't happen often. The position usually gets reconciled when the short covers. imo
Not if they naked shorted above trips and just thought they never had to cover.
“Maintenance Call” lot of that going out next week.
Maybe another chance to load more freebies. I don’t think so tho
I hope so haha
Won’t be “FDBL” for long. Which is why the huge volume. Next week will be interesting
Did you see why
No record date yet so imo you’ll be good
Well you got to first check the filings before coming here confused bro. Hahah. It helps
Shareholders will also receive their share of 400M Fan Pass, Inc shares. Unless the 400M changed but so far the Sec of State in Nevada shows 400M.
The math looks to be about 550 Sharp shares for every 1M FDBL in this reverse merger.
What do you think it’s just some leak that got out lol. All done in a filing. No one knew before the 8-k release
It’s in the filing bro. 8-k
What?
Read the 8-k. Reverse merger with Sharps Technology, Inc.
That’s great. I hope it’s your #4 too haha.
Just wished Robert was more upfront with things but I guess this is the NDA he had said he was bound by. This didn’t just happen this week. Probably took months to pan out.
So now we also have Fan Pass to look forward to. They’ve extended the trademark SOU’s for both TM’s so I gather there is also some action going on over there with that.
Sharps guys are all from my neck of the woods. One of them I saw is from Boston which is pretty cool.
https://www.linkedin.com/in/tony-mulone-97a467ab
I don’t think we’ll have the opportunity to get 1’s again. Not with The bid growing like it did today. I saw 3’s on the ask for about 2 seconds today even.
I mean slapped the ask*
I have a lot of BTC on GDAX and Binance that’s why earlier I was wishing TdAmeritrade accepted BTC. I would have sent some BTC over slapped the bid before anyone else did and added 80M or so more today. Oh well I got enough.
I had 40M on the ask for weeks up until last week when I said screw it and canceled the GTC order
Yes I do have them all. Wasn’t going to sell it at this level that’s for sure. Yes, seems like a solid reverse merger to me. Plus we can continue with Fan Pass dreams after haha.
See 8-k released
SmartShield's products will be distributed by Dgania medical inc. as a managing partner in the new company to be established worldwide via major distributors of medical devices and consumables, as well as major purchasing organizations for hospitals and healthcare facilities. However, in order to ramp up initial sales, the Company will canvass potential clients from a database of 250+ concrete customer enquiries collated during the development process and participation in two annual MEDICA exhibitions. The Company does not plan to become a full logistical operation, but rather to concentrate on developing, manufacturing and marketing its products.
http://www.sharpshieldsyringe.com/business-plan.html
New bosses around here:
CEO - https://www.linkedin.com/in/edgar-nouss
Founder/Director - https://www.linkedin.com/in/dloewenstein
Edgar Nouss is Chief Executive Officer, Sharps Technology, Inc. which is an innovative medical device company with game changing patented sheath technology designed to protect 40 million health care workers from infectious needle stick injuries. Furthermore, the patented sheath technology is designed to protect the population at large from used syringes. Edgar was formerly the Chief Marketing Officer of Merck in Switzerland and in the US. Edgar possess executive leadership skills enabling him to drive revenue and commercialization strategy. Edgar has deep global region and country level leadership skills having worked in Global, US, Japan and Europe.
Education includes: University of Missouri with a BS in Chemistry; Washington University’s John M. Olin School of Business with an MBA, with emphasis on International Business/Management and Executive Leadership Program with the Wharton School of Business.
Sharps has the patent on the needle protective shield. The giants like becton dickinson may be paying Sharps royalty to use the patent imo
And then to have to cover the Fan Pass shares too. Ouch.
I agree with that. We can already see the meltdown by them happening. It will get very loud again around here lol. I’ll hold on to my 1/4 Billion shares.